Modules
Summit Medical Partners, Corp.
Customer 47700
- Account Classification
- Unknown
- Classification Confidence
- Medium
- Sites
- HQ | Vendor | dd97f5167549a50a31b6d66c4386eacb9d59ff63b0aa38a5b02cbaaaef66a15b
- Assigned Reps
- Derek Callahan
- Website
- —
- Active Opportunity Count
- 8
- Published Count
- 0
- Revenue Base
- 0
- Known GPBase
- 0
- Analyzer Platforms
- Parts Group | Immunalysis | MicroGenics
- Product Groups
- Immunalysis | MicroGenics
- Recommended Contact
- Cole Isakov
- Backup Contact
- Sam Kessler | | sam.kessler@gmail.com
- Last Meaningful Activity
- —
- Customer Memory
- Verified transaction fact: platform/product group signal is Parts Group. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified item fact: storage requirement Fridge. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is Immunalysis. Verified item fact: storage requirement Fridge. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is MicroGenics. Verified item fact: storage requirement Fridge. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach.
- Evidence References
- Candidate CAND-253f4e44f7bef4f6e54a3a68633fd728f706ef2d0d438a9e226b091d472562dd | Customer 47700 | Candidate CAND-ebeb7778871401f0ba57d9bc40ade40d00714f0092d1e1c77168183d5981b61e | Customer 47700 | Candidate CAND-7c161c4e512f07c37c18f57e8e7cd3f00d1e6b0df6ab2b4e75ab8eb147705305 | Customer 47700 | Quote 28245 | Item 11433 | Candidate CAND-d486d1d3927ee94ffcd96c428697c3ca9345930e01c66b843a9bc7235f7e7c4b | Customer 47700 | Order 50556 | Item 13054 | Candidate CAND-bc192d499178169af8c5be646af826ed1efe4ac3c8919d956bd912c82a6b6e2d | Customer 47700 | Order 50556 | Item 13064 | Candidate CAND-3703564b662afd0ad8393905fcc127aec8efe432b6ef6884aa562d50aa448827 | Customer 47700 | Order 50556 | Item 13063 | Candidate CAND-9476d1f2258b377c97e85e391a64be7691f4efd2667f883dc2c1ce206ffafbac | Customer 47700 | Order 50786 | Item 13057 | Candidate CAND-944bee39fd0c207cf46b7e1ab8d8fbee22c3e01884e3148a57e4c5904f0a1af5 | Customer 47700 | Order 52243 | Item 11586
Opportunities (16)
| Source Sheet | Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Final Disposition | Assigned Rep | Territory Rep | Source Rep | Customer | Customer ID | Site | City | State | Region | Account Classification | Classification Confidence | Analyzer Platform | Product Group | SKU | Item Description | Quote Doc No | Order Doc No | Deterministic Signal | Revenue Low | Revenue Base | Revenue High | GP Low | GP Base | GP High | Priority Score | Confidence | Open Order | Open Quote | Suppression Status | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Account Risk | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-253f4e44f7bef4f6e54a3a68633fd728f706ef2d0d438a9e226b091d472562dd | OPP-2925f4da431f0012264f720dc32f1988a9608d416aa44525ad4d041d13877c76 | SER-922694b967080f34b28991f892661eb90308520023057a913d1c2bb1fa16f03f | Needs Validation | **** | **** | **** | Summit Medical Partners, Corp. | 47700 | HQ | Bristol | VA | East | Unknown | Medium | Parts Group | — | — | — | — | — | Analyzer Platform Purchasing Loss; 8 independent signals; trailing 90-day revenue $750.00 versus $8742.06; trailing 180-day revenue $9492.06 versus $38284.08; 50 days beyond expected account order date. | 7198.01 | 14396.01 | 21594.02 | 2123.37 | 4246.75 | 6370.12 | 90.87 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-253f4e44f7bef4f6e54a3a68633fd728f706ef2d0d438a9e226b091d472562dd | Customer 47700 |
| Account Risk | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ebeb7778871401f0ba57d9bc40ade40d00714f0092d1e1c77168183d5981b61e | OPP-834043c0a0432707e591ec1ea7b469b7ae4773e587cab1d4b8c5ec6409a3ea38 | SER-f0add73e3249c6e8d41ad12fa20ab4ec37e0394a913d2fdede0d8b5ffb89a969 | Needs Validation | **** | **** | **** | Summit Medical Partners, Corp. | 47700 | Vendor | Bristol | VA | East | Unknown | Medium | — | — | — | — | — | — | Materially Delayed Purchasing; 3 independent signals; trailing 90-day revenue $3208.59 versus $5682.83; trailing 180-day revenue $8891.42 versus $12229.35; 33 days beyond expected account order date. | 1528.67 | 3057.34 | 4586.01 | 340.79 | 681.59 | 1022.38 | 65.42 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-ebeb7778871401f0ba57d9bc40ade40d00714f0092d1e1c77168183d5981b61e | Customer 47700 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-3703564b662afd0ad8393905fcc127aec8efe432b6ef6884aa562d50aa448827 | OPP-fe569707ef1a2f833e350f5691e4944f06d76adba45f01c1be631f8be6cf4b5b | SER-a8b44d7c6664e39bb67008cd36a61eb3aeaf743b8663402d1e4f2442a208cacc | Needs Validation | **** | **** | **** | Summit Medical Partners, Corp. | 47700 | HQ | Bristol | VA | East | Unknown | Medium | Immunalysis | Immunalysis | 307UR-0100 | 307UR-0100 Alere Immunalysis Opiates Reagent, 100mL | — | 50556 | 3 completed purchases over 201 days; median interval 100.5 days; expected reorder 2026-05-29; High Risk by 73 days. | 1225 | 1633.33 | 2041.67 | 264.64 | 352.85 | 441.06 | 61.74 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-3703564b662afd0ad8393905fcc127aec8efe432b6ef6884aa562d50aa448827 | Customer 47700 | Order 50556 | Item 13063 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-bc192d499178169af8c5be646af826ed1efe4ac3c8919d956bd912c82a6b6e2d | OPP-8f111b6a98ed601335b12471ed4ade6b5d748978269c1387d38f288e0b68d152 | SER-b45471449d58db78900501db082f9d53623f5d185fd2418122c1a1427766d842 | Needs Validation | **** | **** | **** | Summit Medical Partners, Corp. | 47700 | HQ | Bristol | VA | East | Unknown | Medium | Immunalysis | Immunalysis | 302UR-0100 | 302UR-0100 Alere Immunalysis Oxycodone Reagent, 100mL | — | 50556 | 3 completed purchases over 201 days; median interval 100.5 days; expected reorder 2026-05-29; High Risk by 73 days. | 1225 | 1633.33 | 2041.67 | 264.64 | 352.85 | 441.06 | 61.74 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-bc192d499178169af8c5be646af826ed1efe4ac3c8919d956bd912c82a6b6e2d | Customer 47700 | Order 50556 | Item 13064 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d486d1d3927ee94ffcd96c428697c3ca9345930e01c66b843a9bc7235f7e7c4b | OPP-efe1898f04d2d71e2c1d42317b38ca0449bafbe787b40e0a18fec2cd2b6417d5 | SER-9d4eb6f19aa47e49045fe2ba1033485b2b1f9deaedbd4540c1d86034bd2bde6b | Needs Validation | **** | **** | **** | Summit Medical Partners, Corp. | 47700 | HQ | Bristol | VA | East | Unknown | Medium | Immunalysis | Immunalysis | 309UR-0100 | 309UR-0100 Alere Immunalysis Amphetamine Reagent, 100mL | — | 50556 | 3 completed purchases over 201 days; median interval 100.5 days; expected reorder 2026-05-29; High Risk by 73 days. | 1225 | 1633.33 | 2041.67 | 264.64 | 352.85 | 441.06 | 61.74 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-d486d1d3927ee94ffcd96c428697c3ca9345930e01c66b843a9bc7235f7e7c4b | Customer 47700 | Order 50556 | Item 13054 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9476d1f2258b377c97e85e391a64be7691f4efd2667f883dc2c1ce206ffafbac | OPP-fa2f0250abc260147a53a1fded35d2fd098227c2d9f876de94321704b46d4967 | SER-c4c3f3fe387e263119a4ab9356362a1f15569fbcf7b6f9ab9e11af75eb115fc7 | Needs Validation | **** | **** | **** | Summit Medical Partners, Corp. | 47700 | HQ | Bristol | VA | East | Unknown | Medium | Immunalysis | Immunalysis | 306UR-0100 | 306UR-0100 Alere Immunalysis Benzoylecgonine Reagent, 100mL | — | 50786 | 3 completed purchases over 190 days; median interval 95.0 days; expected reorder 2026-06-05; High Risk by 66 days. | 908.46 | 1211.29 | 1514.11 | 278.1 | 370.8 | 463.5 | 60.06 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-9476d1f2258b377c97e85e391a64be7691f4efd2667f883dc2c1ce206ffafbac | Customer 47700 | Order 50786 | Item 13057 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-944bee39fd0c207cf46b7e1ab8d8fbee22c3e01884e3148a57e4c5904f0a1af5 | OPP-2645140e80030ce3e798f317e8f4e4747dba880772ad96bfb8ac7ffb5f6bb720 | SER-60e86cb106114193e74ac9980eeb97f9b401c5205ecdd87b05a37a9cb7f17d45 | Needs Validation | **** | **** | **** | Summit Medical Partners, Corp. | 47700 | Vendor | Bristol | VA | East | Unknown | Medium | MicroGenics | MicroGenics | T-100249 | Thermo Kit Oxycodone 500mL | — | 52243 | 3 completed purchases over 139 days; median interval 69.5 days; expected reorder 2026-08-10; Due Soon by 0 days. | 1081.93 | 1442.57 | 1803.22 | 137.95 | 183.93 | 229.91 | 55.01 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-944bee39fd0c207cf46b7e1ab8d8fbee22c3e01884e3148a57e4c5904f0a1af5 | Customer 47700 | Order 52243 | Item 11586 |
| Quote Leakage | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7c161c4e512f07c37c18f57e8e7cd3f00d1e6b0df6ab2b4e75ab8eb147705305 | OPP-72676a0657ad417be4cf9e9d6fbc337095e7db82ee5b45c4f6738de29cd6334a | SER-0d2649d306e75a8d3001d69f5f6e58278e5a4ebbef63cb9d67a982644f481bb6 | Needs Validation | **** | **** | **** | Summit Medical Partners, Corp. | 47700 | — | Bristol | VA | East | Unknown | Medium | — | MicroGenics | T-0018 | Thermo Kit Amph 500mL | 28245 | — | Stale Open Quote on quote 28245; quote age 279 days; last modified 277 days ago; quoted value $8289.08; converted line value $0.00; unconverted line value $8289.08. | 828.91 | 1657.82 | 2486.72 | 105.84 | 211.69 | 317.53 | 68.76 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-7c161c4e512f07c37c18f57e8e7cd3f00d1e6b0df6ab2b4e75ab8eb147705305 | Customer 47700 | Quote 28245 | Item 11433 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-253f4e44f7bef4f6e54a3a68633fd728f706ef2d0d438a9e226b091d472562dd | OPP-2925f4da431f0012264f720dc32f1988a9608d416aa44525ad4d041d13877c76 | SER-922694b967080f34b28991f892661eb90308520023057a913d1c2bb1fa16f03f | — | **** | — | — | Summit Medical Partners, Corp. | 47700 | HQ | — | VA | — | — | — | Parts Group | — | — | — | — | — | Analyzer Platform Purchasing Loss; 8 independent signals; trailing 90-day revenue $750.00 versus $8742.06; trailing 180-day revenue $9492.06 versus $38284.08; 50 days beyond expected account order date. | — | 14396.01 | — | — | 4246.75 | — | 90.87 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-253f4e44f7bef4f6e54a3a68633fd728f706ef2d0d438a9e226b091d472562dd | Customer 47700 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ebeb7778871401f0ba57d9bc40ade40d00714f0092d1e1c77168183d5981b61e | OPP-834043c0a0432707e591ec1ea7b469b7ae4773e587cab1d4b8c5ec6409a3ea38 | SER-f0add73e3249c6e8d41ad12fa20ab4ec37e0394a913d2fdede0d8b5ffb89a969 | — | **** | — | — | Summit Medical Partners, Corp. | 47700 | Vendor | — | VA | — | — | — | — | — | — | — | — | — | Materially Delayed Purchasing; 3 independent signals; trailing 90-day revenue $3208.59 versus $5682.83; trailing 180-day revenue $8891.42 versus $12229.35; 33 days beyond expected account order date. | — | 3057.34 | — | — | 681.59 | — | 65.42 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-ebeb7778871401f0ba57d9bc40ade40d00714f0092d1e1c77168183d5981b61e | Customer 47700 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-3703564b662afd0ad8393905fcc127aec8efe432b6ef6884aa562d50aa448827 | OPP-fe569707ef1a2f833e350f5691e4944f06d76adba45f01c1be631f8be6cf4b5b | SER-a8b44d7c6664e39bb67008cd36a61eb3aeaf743b8663402d1e4f2442a208cacc | — | **** | — | — | Summit Medical Partners, Corp. | 47700 | HQ | — | VA | — | — | — | Immunalysis | — | — | — | — | — | 3 completed purchases over 201 days; median interval 100.5 days; expected reorder 2026-05-29; High Risk by 73 days. | — | 1633.33 | — | — | 352.85 | — | 61.74 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-3703564b662afd0ad8393905fcc127aec8efe432b6ef6884aa562d50aa448827 | Customer 47700 | Order 50556 | Item 13063 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-bc192d499178169af8c5be646af826ed1efe4ac3c8919d956bd912c82a6b6e2d | OPP-8f111b6a98ed601335b12471ed4ade6b5d748978269c1387d38f288e0b68d152 | SER-b45471449d58db78900501db082f9d53623f5d185fd2418122c1a1427766d842 | — | **** | — | — | Summit Medical Partners, Corp. | 47700 | HQ | — | VA | — | — | — | Immunalysis | — | — | — | — | — | 3 completed purchases over 201 days; median interval 100.5 days; expected reorder 2026-05-29; High Risk by 73 days. | — | 1633.33 | — | — | 352.85 | — | 61.74 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-bc192d499178169af8c5be646af826ed1efe4ac3c8919d956bd912c82a6b6e2d | Customer 47700 | Order 50556 | Item 13064 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d486d1d3927ee94ffcd96c428697c3ca9345930e01c66b843a9bc7235f7e7c4b | OPP-efe1898f04d2d71e2c1d42317b38ca0449bafbe787b40e0a18fec2cd2b6417d5 | SER-9d4eb6f19aa47e49045fe2ba1033485b2b1f9deaedbd4540c1d86034bd2bde6b | — | **** | — | — | Summit Medical Partners, Corp. | 47700 | HQ | — | VA | — | — | — | Immunalysis | — | — | — | — | — | 3 completed purchases over 201 days; median interval 100.5 days; expected reorder 2026-05-29; High Risk by 73 days. | — | 1633.33 | — | — | 352.85 | — | 61.74 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-d486d1d3927ee94ffcd96c428697c3ca9345930e01c66b843a9bc7235f7e7c4b | Customer 47700 | Order 50556 | Item 13054 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9476d1f2258b377c97e85e391a64be7691f4efd2667f883dc2c1ce206ffafbac | OPP-fa2f0250abc260147a53a1fded35d2fd098227c2d9f876de94321704b46d4967 | SER-c4c3f3fe387e263119a4ab9356362a1f15569fbcf7b6f9ab9e11af75eb115fc7 | — | **** | — | — | Summit Medical Partners, Corp. | 47700 | HQ | — | VA | — | — | — | Immunalysis | — | — | — | — | — | 3 completed purchases over 190 days; median interval 95.0 days; expected reorder 2026-06-05; High Risk by 66 days. | — | 1211.29 | — | — | 370.8 | — | 60.06 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-9476d1f2258b377c97e85e391a64be7691f4efd2667f883dc2c1ce206ffafbac | Customer 47700 | Order 50786 | Item 13057 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-944bee39fd0c207cf46b7e1ab8d8fbee22c3e01884e3148a57e4c5904f0a1af5 | OPP-2645140e80030ce3e798f317e8f4e4747dba880772ad96bfb8ac7ffb5f6bb720 | SER-60e86cb106114193e74ac9980eeb97f9b401c5205ecdd87b05a37a9cb7f17d45 | — | **** | — | — | Summit Medical Partners, Corp. | 47700 | Vendor | — | VA | — | — | — | MicroGenics | — | — | — | — | — | 3 completed purchases over 139 days; median interval 69.5 days; expected reorder 2026-08-10; Due Soon by 0 days. | — | 1442.57 | — | — | 183.93 | — | 55.01 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-944bee39fd0c207cf46b7e1ab8d8fbee22c3e01884e3148a57e4c5904f0a1af5 | Customer 47700 | Order 52243 | Item 11586 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7c161c4e512f07c37c18f57e8e7cd3f00d1e6b0df6ab2b4e75ab8eb147705305 | OPP-72676a0657ad417be4cf9e9d6fbc337095e7db82ee5b45c4f6738de29cd6334a | SER-0d2649d306e75a8d3001d69f5f6e58278e5a4ebbef63cb9d67a982644f481bb6 | — | **** | — | — | Summit Medical Partners, Corp. | 47700 | — | — | VA | — | — | — | — | — | — | — | — | — | Stale Open Quote on quote 28245; quote age 279 days; last modified 277 days ago; quoted value $8289.08; converted line value $0.00; unconverted line value $8289.08. | — | 1657.82 | — | — | 211.69 | — | 68.76 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-7c161c4e512f07c37c18f57e8e7cd3f00d1e6b0df6ab2b4e75ab8eb147705305 | Customer 47700 | Quote 28245 | Item 11433 |